Supportive Oncology Research Group shared a post on LinkedIn:
“SORG postdoctoral fellow, Dr. Courtney Cross, taking the stage at COSA-IPOS 2025 highlighting how microbiome screening can help personalise cancer care by predicting side effects.”
More posts from COSA-IPOS 2025.